Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man.
Venugopal
Supriya S
SS
Department of Dermatology, St George Hospital, University of New South Wales, Kogarah, Sydney, New South Wales 2217, Australia.
Murrell
Dedee F
DF
D000328:Adult; D002648:Child; D002658:Developmental Disabilities / Q000150:complications; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000628:therapy* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D012307:Risk Factors; D014860:Warts / Q000628:therapy* / Q000821:virology
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines